BeStock  
Stocks › Biotechnology › VIR

Vir Biotechnology VIR

US equityMarket cap rank #2845Biotechnology
$8.39 −$0.48 (-5.41%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.30 -1.05%
Open$8.77
Prev close$8.87
Day range$8.34 – $8.92
Volume3.09M
Market cap$1.56B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue-$200,000.00-207.7% YoY
Operating profit-$104.66M+39.7% YoY
Net profit-$96.25M+41.0% YoY
Diluted EPS-$0.57+51.3% YoY
Free cash flow-$106.12M+36.8% YoY
Operating cash flow-$106.08M

Revenue, last 8 quarters

$11.3MDec '24$1.8MMar '25$1.0MJun '25$-65.0KSep '25$63.8MDec '25$-41.0KMar '26$238.9MJun '26$-200.0KSep '26

Net profit, last 8 quarters

$-104.6MDec '24$-121.0MMar '25$-111.0MJun '25$-163.1MSep '25$-42.9MDec '25$-125.7MMar '26$80.1MJun '26$-96.3MSep '26

Diluted EPS by quarter

-0.76Dec '24-0.88Mar '25-0.80Jun '25-1.17Sep '25-0.31Dec '25-0.85Mar '260.47Jun '26-0.57Sep '26

Free cash flow by quarter

$-89.6MDec '24$-79.7MMar '25$-122.8MJun '25$-167.9MSep '25$-26.2MDec '25$-132.8MMar '26$123.3MJun '26$-106.1MSep '26

Annual revenue

$67.2MFY20$1.1BFY21$1.6BFY22$39.5MFY23$63.7MFY24$66.5MFY25

Profitability & balance sheet

Gross margin100.0%
Operating margin-69.9%
Net margin-61.1%
Return on equity-21.8%
Return on assets-17.3%
Return on invested capital-21.7%
Current ratio6.30
Liabilities / assets19.4%
Cash & investments$458.36M
Total debt$81.46M
Net cash (debt)$376.90M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported -$188,000.00 $238.95M -$29,000.00 $68.56M $64.07M
Total Operating Revenue -$200,000.00 $238.94M -$41,000.00 $66.52M $63.76M
Cost of Revenue $0.00 $0.00 – $26,000.00 $26,000.00
Gross Profit -$200,000.00 $238.94M – $66.49M $63.73M
Operating Expense $104.46M $165.47M $132.25M $546.00M $111.66M
Selling and Admin Expenses $24.43M $30.20M $23.34M $92.07M $23.62M
Research & Development $80.04M $135.28M $108.92M $455.97M $88.35M
Other Operating Expenses -$12,000.00 -$11,000.00 -$12,000.00 -$2.04M -$310,000.00
Operating Profit -$104.66M $73.47M -$132.29M -$479.51M -$47.92M
Net Non-Operating Interest Income (Expense) $9.32M $8.97M $7.19M $40.24M $7.80M
Non-Operating Interest Income $9.32M $8.97M $7.19M $40.24M $7.80M
Other Income (Expense) -$1.06M -$2.17M -$424,000.00 $1.50M -$2.94M
Gain on Sale of Security -$409,000.00 -$1.72M -$170,000.00 $1.73M -$2.61M
Special Income (Charges) $0.00 $0.00 $0.00 $182,000.00 $0.00
-Less:Restructuring and Mergern & Acquisition $0.00 $0.00 $0.00 -$182,000.00 $0.00
Other Non-Operating Income (Expenses) -$651,000.00 -$451,000.00 -$254,000.00 -$409,000.00 -$335,000.00
Pretax Profit -$96.40M $80.26M -$125.53M -$437.77M -$43.06M
Tax -$143,000.00 $179,000.00 $170,000.00 $217,000.00 -$137,000.00
Net Profit -$96.25M $80.08M -$125.70M -$437.99M -$42.92M
Profit from Continuing Operations -$96.25M $80.08M -$125.70M -$437.99M -$42.92M
Net Income to Parent Company -$96.25M $80.08M -$125.70M -$437.99M -$42.92M
Net Income to Common Stockholders -$96.25M $80.08M -$125.70M -$437.99M -$42.92M
Basic EPS -$0.57 $0.48 -$0.85 -$3.16 -$0.31
Diluted EPS -$0.57 $0.47 -$0.85 -$3.16 -$0.31
Minority Interests – – – $0.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.11B $1.21B $1.03B $1.00B $1.00B
Total Current Assets $508.27M $573.74M $522.99M $514.08M $514.08M
Cash and Cash Equivalents & Short-Term Investments $458.36M $532.73M $476.30M $467.02M $467.02M
-Cash and Cash Equivalents $218.87M $278.73M $274.16M $232.19M $232.19M
-Short Term Investments $239.49M $254.00M $202.14M $234.83M $234.83M
Restricted Cash $1.93M $1.93M $1.93M $1.92M $1.92M
Other Current Assets $47.98M $39.08M $44.76M $45.14M $45.14M
Total Non-Current Assets $603.58M $641.07M $502.60M $488.74M $488.74M
Net PPE $105.76M $109.82M $113.92M $117.72M $117.72M
-Gross PPE $161.08M $162.45M $163.82M $164.88M $164.88M
-Accumulated Depreciation -$55.32M -$52.63M -$49.90M -$47.16M -$47.16M
Investments and Advances $442.93M $475.02M $332.97M $314.58M $314.58M
-Available for Sale Securities $442.93M $475.02M $332.97M $314.58M $314.58M
Goodwill and Other Intangible Assets $24.57M $24.64M $24.71M $24.79M $24.79M
-Goodwill $16.94M $16.94M $16.94M $16.94M $16.94M
-Other Intangible Assets $7.63M $7.70M $7.78M $7.85M $7.85M
Other Non-Current Assets $30.32M $31.59M $31.00M $31.66M $31.66M
Total Liabilities $215.82M $232.31M $212.82M $237.55M $237.55M
Total Current Liabilities $80.66M $94.96M $73.56M $92.82M $92.82M
Payables $13.16M $19.59M $7.27M $11.63M $11.63M
-Accounts Payable $11.32M $17.75M $5.45M $9.80M $9.80M
-Other Payable $1.84M $1.83M $1.83M $1.83M $1.83M
Current Accrued Expenses $58.18M $66.24M $57.34M $72.39M $72.39M
Short-Term Debt and Capital Lease Obligation $9.32M $9.14M $8.94M $8.80M $8.80M
-Current Capital Lease Obligation $9.32M $9.14M $8.94M $8.80M $8.80M
Total Non-Current Liabilities $135.16M $137.35M $139.26M $144.73M $144.73M
Long Term Debt and Capital Lease Obligation $81.46M $84.14M $86.64M $89.05M $89.05M
-Long Term Capital Lease Obligation $81.46M $84.14M $86.64M $89.05M $89.05M
Other Non-Current Liabilities $53.70M $53.22M $52.63M $55.68M $55.68M
Total Equity $896.04M $982.49M $812.77M $765.28M $765.28M
Stockholders' Equity $896.04M $982.49M $812.77M $765.28M $765.28M
Capital Stock $17,000.00 $17,000.00 $16,000.00 $14,000.00 $14,000.00
-Common Stock $17,000.00 $17,000.00 $16,000.00 $14,000.00 $14,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $2.24B $2.23B $2.14B $1.97B $1.97B
Retained Earnings -$1.34B -$1.24B -$1.32B -$1.20B -$1.20B
Gains/Losses Not Affecting Retained Earnings -$6.90M -$4.60M -$3.48M -$2.06M -$2.06M
Current Deferred Liabilities – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$106.08M $123.33M -$132.39M -$391.78M -$25.88M
Net cash flow from continuing operations -$106.08M $123.33M -$132.39M -$391.78M -$25.88M
Net Income from Continuing Operations -$96.25M $80.08M -$125.70M -$437.99M -$42.92M
Depreciation & Depletion & Amortization $2.77M $2.80M $2.81M $11.68M $2.90M
Other Non-Cash Items $198,000.00 $2.42M $530,000.00 $156,000.00 $1.63M
Change in Working Capital -$22.80M $23.47M -$22.68M -$22.45M -$2.84M
-Change in Prepaid Assets -$8.90M $5.68M $382,000.00 $2.08M -$8.08M
-Change in Payables and Accrued Expense -$12.64M $20.70M -$21.45M -$4.51M $16.27M
-Change in Other Current Assets $1.24M -$604,000.00 $657,000.00 -$12.64M -$8.72M
-Change in Other Current Liabilities -$2.50M -$2.31M -$2.27M -$7.37M -$2.32M
Net cash flow from investing $44.56M -$197.14M $11.84M $310.37M $86.65M
Net Cash Flow from Continuing Investing Activities $44.56M -$197.14M $11.84M $310.37M $86.65M
Net PPE Purchase and Sale -$34,000.00 -$32,000.00 -$390,000.00 -$4.58M -$458,000.00
Net Investment Purchase and Sale $44.59M -$197.11M $12.23M $314.95M $87.11M
Financing Cash Flow $1.63M $78.38M $162.52M $3.79M $1.04M
Net Cash Flow from Continuing Financing Activities $1.63M $78.38M $162.52M $3.79M $1.04M
Net Common Stock Issuance $0.00 $75.58M $162.35M – –
Proceeds from Stock Option Exercised $1.63M $2.80M $174,000.00 $4.15M $1.04M
Ending Cash Balance $227.71M $287.60M $283.04M $241.07M $241.07M
Net Change in Cash -$59.89M $4.56M $41.97M -$77.63M $61.81M
Beginning Cash Balance $287.60M $283.04M $241.07M $318.70M $179.26M
Free Cash Flow -$106.12M $123.29M -$132.78M -$396.61M -$26.22M
Net Other Financing Charges – – – -$361,000.00 -$2,000.00

Discussion

No comments yet — be the first to weigh in on VIR.

Sign in to join the discussion.

Scroll to Top